The article discusses research which found an association between radioactive iodine (RAI) treatment for hyperthyroidism with increased cancer death risk from solid cancers, particularly breast cancer. It references a study by C. M. Kitahara et al published in a previous issue of "JAMA Internal Medicine." Topics covered include organs that are exposed during treatment, and the dose-response relationship between the dose absorbed by an organ and death from cancer.